OverviewChartNewsTraderScreen

MannKind Corp/  US56400P7069  /

IEX
10/3/2023  9:59:58 PM Chg. -0.14 Volume Bid- Ask- High Low
3.88USD -3.60% 44,861
Turnover: 176,969.84		 -Bid Size: - -Ask Size: - 4.09 3.86
GlobeNewswire 3/28/2022 MannKind Corporation to Participate in the Lytham Partners Spring 2022 Investor Conference
GlobeNewswire 3/22/2022 MannKind Corporation to Participate in the Cantor Virtual Rare Orphan Disease Summit
GlobeNewswire 3/8/2022 MannKind Corporation to Participate in Oppenheimer 32nd Annual Healthcare Conference
GlobeNewswire 2/24/2022 MannKind Corporation Reports 2021 Fourth Quarter and Full Year Financial Results
GlobeNewswire 2/24/2022 Update on Tyvaso DPI™ New Drug Application
GlobeNewswire 2/21/2022 MannKind Corporation to Hold 2021 Fourth Quarter and Full Year Financial Results Conference Call on ...
GlobeNewswire 2/10/2022 MannKind Corporation to Participate in SVB Leerink 2022 Global Healthcare Conference
GlobeNewswire 1/5/2022 MannKind Corporation to Participate in H.C. Wainwright Bioconnect Conference
GlobeNewswire 1/5/2022 MannKind Extends Collaboration With Thirona Bio on Fibrotic Lung Diseases
GlobeNewswire 12/6/2021 MannKind Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference
GlobeNewswire 11/16/2021 NRx Pharmaceuticals Reports Third-Quarter 2021 Business Update and Financial Results
GlobeNewswire 11/9/2021 MannKind Corporation Reports 2021 Third Quarter Financial Results
GlobeNewswire 11/9/2021 Mannkind Corporation Closes Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gr...
GlobeNewswire 11/5/2021 MannKind Presents Data at 21st Annual Diabetes Technology Meeting
GlobeNewswire 11/2/2021 MannKind Corporation to Hold 2021 Third Quarter Financial Results Conference Call on November 9, 202...
GlobeNewswire 10/18/2021 Progress Update on Tyvaso DPI™ New Drug Application
GlobeNewswire 10/4/2021 MannKind Announces First Patient Enrolled in INHALE-1 Study of Afrezza® in Pediatric Population
GlobeNewswire 9/28/2021 MannKind Corporation to Participate at Lytham Partners Fall 2021 Investor Conference
GlobeNewswire 9/15/2021 Mannkind Corporation Participating at Upcoming Conferences
GlobeNewswire 9/7/2021 MannKind Corporation to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire 8/11/2021 MannKind Corporation Reports 2021 Second Quarter Financial Results
GlobeNewswire 8/4/2021 MannKind Corporation to Hold 2021 Second Quarter Financial Results Conference Call on August 11, 202...
GlobeNewswire 8/3/2021 MannKind Corporation to Participate in the BTIG Virtual Biotechnology Conference 2021
GlobeNewswire 6/16/2021 MannKind and United Therapeutics Achieve a Major Milestone in the Development of Tyvaso DPI™ With Ne...
GlobeNewswire 6/10/2021 MannKind and Thirona Bio Join Forces to Evaluate Potential Inhaled Therapy for Fibrotic Lung Disease...